PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.32%
Negative revenue growth while ADI stands at 8.01%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.87%
Negative gross profit growth while ADI is at 7.22%. Joel Greenblatt would examine cost competitiveness or demand decline.
-72.60%
Negative EBIT growth while ADI is at 9.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-51.78%
Negative operating income growth while ADI is at 9.83%. Joel Greenblatt would press for urgent turnaround measures.
-53.37%
Negative net income growth while ADI stands at 9.73%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-49.18%
Negative EPS growth while ADI is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-49.18%
Negative diluted EPS growth while ADI is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.03%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.23%
Slight or no buyback while ADI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
0.66%
Dividend growth of 0.66% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
329.17%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
25.90%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
53.79%
10Y revenue/share CAGR under 50% of ADI's 175.76%. Michael Burry would suspect a lasting competitive disadvantage.
17.67%
5Y revenue/share CAGR under 50% of ADI's 38.74%. Michael Burry would suspect a significant competitive gap or product weakness.
-2.29%
Negative 3Y CAGR while ADI stands at 40.28%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
582.23%
Positive OCF/share growth while ADI is negative. John Neff might see a comparative advantage in operational cash viability.
-38.49%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
392.80%
10Y net income/share CAGR of 392.80% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
140.03%
Below 50% of ADI's 333.33%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-41.82%
Negative 3Y CAGR while ADI is 225.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
80.63%
5Y equity/share CAGR above 1.5x ADI's 38.08%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
71.68%
3Y equity/share CAGR above 1.5x ADI's 41.35%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
104.00%
Dividend/share CAGR of 104.00% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-78.68%
Negative 5Y dividend/share CAGR while ADI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
15.10%
3Y dividend/share CAGR of 15.10% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-3.94%
Firm’s AR is declining while ADI shows 11.76%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.35%
Inventory shrinking or stable vs. ADI's 21.36%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
1.30%
Asset growth well under 50% of ADI's 4.76%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.11%
Under 50% of ADI's 56.29%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
14.36%
Debt growth far above ADI's 2.90%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-3.29%
Our R&D shrinks while ADI invests at 9.54%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.26%
SG&A growth well above ADI's 2.46%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.